Roche
ROG.SW
$279.67
Share price
-1.97%
Change (1 day)
-14.12%
Change (1 year)
Categories
Roche (ROG.SW) - Total liabilities
Total liabilities on the balance sheet as of December 2022 : $60.76 B
According to Roche's latest financial reports the company's total liabilities are $60.76 B. A company’s total liabilities is the sum of all current and non-current debts and obligations.
Roche - Total liabilities on balance sheet (from 2006 to 2022)
Total liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2022-12-31 | $60.76 B | -13.21% |
| 2021-12-31 | $70.01 B | 33.12% |
| 2020-12-31 | $52.59 B | 7.88% |
| 2019-12-31 | $48.75 B | -0.41% |
| 2018-12-31 | $48.95 B | -0% |
| 2017-12-31 | $48.95 B | -1.08% |
| 2016-12-31 | $49.49 B | -6.8% |
| 2015-12-31 | $53.10 B | -2.94% |
| 2014-12-31 | $54.70 B | 18.6% |
| 2013-12-31 | $46.12 B | -12.44% |
| 2012-12-31 | $52.68 B | 4.94% |
| 2011-12-31 | $50.20 B | -4.95% |
| 2010-12-31 | $52.81 B | -16.16% |
| 2009-12-31 | $62.99 B | 195.05% |
| 2008-12-31 | $21.35 B | -2.84% |
| 2007-12-31 | $21.97 B | -3.13% |
| 2006-12-31 | $22.68 B | 8.07% |
| 2005-12-31 | $20.99 B | -3.39% |
| 2004-12-31 | $21.72 B | -11.38% |
| 2003-12-31 | $24.52 B | -43.64% |
| 2002-12-31 | $43.50 B | -7.72% |
| 2001-12-31 | $47.14 B |
Total liabilities for similar companies or competitors
| Company | Total liabilities | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $125.10 B | 105.87% | 🇺🇸 USA |
 Novartis NVS | $59.04 B | -2.83% | 🇨🇭 Switzerland |
 Pfizer PFE | $94.38 B | 55.32% | 🇺🇸 USA |
 Abbott Laboratories ABT | $36.56 B | -39.83% | 🇺🇸 USA |
 Amgen AMGN | $83.48 B | 37.39% | 🇺🇸 USA |
 Sanofi SNY | $56.95 B | -6.27% | 🇫🇷 France |
 Becton Dickinson BDX | $27.08 B | -55.44% | 🇺🇸 USA |
 Merck MRK | $60.89 B | 0.21% | 🇺🇸 USA |
 GlaxoSmithKline GSK | $59.66 B | -1.80% | 🇬🇧 UK |